HIV News and Research RSS Feed - HIV News and Research

Mylan receives shareholders' approval for proposed Perrigo acquisition

Mylan receives shareholders' approval for proposed Perrigo acquisition

Mylan N.V. today announced that its shareholders have approved Mylan's proposed acquisition of Perrigo Company plc and the related issuance of Mylan ordinary shares to Perrigo's shareholders at an extraordinary general meeting of shareholders held today. [More]
Cell-to-cell transmission of HIV leads to development of AIDS

Cell-to-cell transmission of HIV leads to development of AIDS

Researchers from the Gladstone Institutes have revealed that HIV does not cause AIDS by the virus's direct effect on the host's immune cells, but rather through the cells' lethal influence on one another. [More]

Researchers reveal HIV testing trends among older adults

Researchers led by the UCLA Fielding School of Public Health examined HIV testing trends among adults ages 50 through 64 both before and after 2006, when the Centers for Disease Control and Prevention (CDC) recommended that most doctors automatically screen all patients for HIV regardless of whether they have symptoms. [More]
Global life expectancy climbs, but people live longer with illnesses

Global life expectancy climbs, but people live longer with illnesses

Global life expectancy has risen by more than six years since 1990 as healthy life expectancy grows; ischemic heart disease, lower respiratory infections, and stroke cause the most health loss around the world. [More]
Antiviral-based therapies have potential to protect humans from deadly Ebola virus

Antiviral-based therapies have potential to protect humans from deadly Ebola virus

For the first time, UK physicians have demonstrated that antiviral-based therapies have the potential to protect humans from the deadly Ebola virus. The report, published in The Lancet Infectious Diseases journal, describes a case-series of eight British health-care workers who were evacuated to the Royal Free Hospital in London, UK after possible accidental exposure to Ebola virus in Sierra Leone between January and March 2015. [More]
Only one in five gay and bisexual teen boys tested for HIV

Only one in five gay and bisexual teen boys tested for HIV

Young men who have sex with men have the highest risk for HIV infection, but only one in five has ever been tested for HIV, a much lower rate than testing for non-adolescents, reports a new national Northwestern Medicine study conducted in partnership with the Center for Innovative Public Health Research. [More]
New studies evaluate viral suppression rate of HIV-infected pregnant women at delivery

New studies evaluate viral suppression rate of HIV-infected pregnant women at delivery

Pregnancy could be a turning point for HIV-infected women, when they have the opportunity to manage their infection, prevent transmission to their new baby and enter a long-term pattern of maintenance of HIV care after giving birth--but most HIV-infected women aren't getting that chance. [More]
Elite CBD Remedy Tincture now available through Mary's Nutritionals

Elite CBD Remedy Tincture now available through Mary's Nutritionals

Elite Botanicals, the leading cultivator of CBD-rich hemp in Colorado, today announced that it's Elite CBD Remedy Tincture is now available through medical and recreational dispensaries in Colorado, as well as online through Mary's Nutritionals. [More]
Mylan releases generic version of Zosyn Injection in the U.S.

Mylan releases generic version of Zosyn Injection in the U.S.

Mylan N.V. today announced the U.S. launch of Piperacillin and Tazobactam for Injection USP, 3.375g Single-dose Vials, which is the generic version of Pfizer's Zosyn Injection. [More]
CONRAD announces new funding agreement to increase HIV prevention products for high risk women in Africa

CONRAD announces new funding agreement to increase HIV prevention products for high risk women in Africa

CONRAD is pleased to announce a new funding agreement, in collaboration with the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development, in support of a human centered design (HCD) strategy to increase demand, use and adherence of HIV prevention products for high risk women in Africa. [More]
White sexual-minority men have higher positive racial attitudes, empathy than white heterosexual men

White sexual-minority men have higher positive racial attitudes, empathy than white heterosexual men

White sexual-minority men may be more empathic toward other minority groups compared to their heterosexual white peers. A new study from the University of Houston College of Education compared the attitudes of white heterosexual men to those of white sexual-minority men. [More]
Researchers find that humans carry more antibiotic-resistant staphylococci than farm animals

Researchers find that humans carry more antibiotic-resistant staphylococci than farm animals

Antibiotic-resistant bacteria are a concern for the health and well-being of both humans and farm animals. One of the most common and costly diseases faced by the dairy industry is bovine mastitis, a potentially fatal bacterial inflammation of the mammary gland (IMI). Widespread use of antibiotics to treat the disease is often blamed for generating antibiotic-resistant bacteria. [More]
Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

In response to the growing opioid crisis, several states, including Massachusetts and Rhode Island, have granted pharmacists the authority to provide naloxone rescue kits without a prescription to at-risk patients. This model of pharmacy-based naloxone (PBN) education and distribution is one of the public health strategies currently being evaluated at hundreds of pharmacies in both states to determine the impact on opioid overdose death rates. [More]
Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma Limited, a clinical-stage biotechnology company, is pleased to announce the closing of its U.S. initial public offering of 1,500,000 American Depositary Shares (ADSs), representing 30,000,000 fully paid ordinary shares of Benitec, together with warrants to purchase 500,000 ADSs, representing 10,000,000 fully paid ordinary shares. [More]
Special issue of SAGE's JERHRE presents guidelines, new resources to improve data sharing across the globe

Special issue of SAGE's JERHRE presents guidelines, new resources to improve data sharing across the globe

With the globalization of biomedical research and growing concerns about possible pandemics of diseases such as HIV, SARS, and Ebola, international data-sharing practices are of growing interest to the biomedical science community. But what are the advantages and disadvantages of sharing data in low and middle-income settings? What challenges stand in the way for researchers in countries such as India, Kenya, and Vietnam? A new special issue of SAGE's Journal of Empirical Research on Human Research Ethics presents guidelines, protocols, models, and new resources to improve data sharing across the globe. [More]
Three projects that focus on improving global health win DEBUT Challenge

Three projects that focus on improving global health win DEBUT Challenge

Three unique projects focused on improving global health won the National Institutes of Health's Design by Biomedical Undergraduate Teams (DEBUT) Challenge. The winners showed exemplary initiative in designing tools for a less expensive, portable device to monitor HIV treatment, a new surgical clamp to treat drooping eyelids, and a low-cost patient monitor. [More]
New scientific conference 'Aspirin in the 21st Century' to be held in London

New scientific conference 'Aspirin in the 21st Century' to be held in London

What more can be said about aspirin, a medicine that was first prescribed at the end of the 19th century? It is known and accepted in every country. For over a hundred years it has been the standard by which all other, newer, painkillers have had to be judged, and it has never been found to be inferior. It is still considered the world's leading analgesic. [More]

AfroCentric, FICO partner to offer payment integrity platform to reduce healthcare fraud in South Africa

The AfroCentric Health Group and global analytics software firm FICO today announced a strategic partnership that establishes the South African healthcare industry's leading fraud management solution. AfroCentric's healthcare IT services subsidiary, Helios IT Solutions, and FICO now offer this fraud management and payment integrity platform to all medical schemes in South Africa. [More]
Alere's HIV diagnostics products recognised with Frost & Sullivan's 2015 Product Line Strategy Leadership award

Alere's HIV diagnostics products recognised with Frost & Sullivan's 2015 Product Line Strategy Leadership award

Based on its recent analysis of the HIV diagnostics market, Frost & Sullivan recognises Alere with the 2015 African Frost & Sullivan Award for Product Line Strategy Leadership. Alere has marched steadily to the top of the HIV diagnostic space with its array of testing products that deliver accurate results and leverage cost-effective technologies. It has one of the largest ranges of HIV diagnostic products in the African region. [More]
Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS). [More]
Advertisement